A breakthrough antiviral compound has halted long COVID symptoms in mice, offering new hope for human treatments. Here’s what researchers discovered in 2025.
ASSURE In the News
A breakthrough antiviral compound has halted long COVID symptoms in mice, offering new hope for human treatments. Here’s what researchers discovered in 2025.
Explore the latest science behind Long COVID in 2025, including symptoms, risks, recovery trends, and long-term health impacts of SARS-CoV-2 infection
Discover how recent March 2025 federal cuts to COVID-19 funding impact local health departments, testing access, and pandemic preparedness across the U.S.
Explore the implications of the Trump administration’s $11.4 billion cut in COVID-19 funding to local health departments, affecting testing, research, and public health jobs.
Explore how rapid test innovations from the COVID-19 pandemic are revolutionizing diagnostics for various diseases, including STIs and mpox.
Stay informed about COVID-19 in 2025, including emerging variants like XEC, updated vaccination recommendations, and the importance of rapid testing.
Explore recent findings on long COVID, its persistent symptoms, affected populations, and advancements in treatment options for COVID-19 survivors.
Learn how the ASSURE-100 Rapid COVID-19 Test was developed in Hawaii by Oceanit to improve detection, testing speed, and public health preparedness.
New research explores how long COVID affects daily life, work, and health. Learn about symptoms, treatments, and the latest updates from scientists in 2025.
After five years of COVID-19, what were the biggest misconceptions about the virus and pandemic? Learn key lessons and how we adapted.